Aberdeen Group’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.5M | Buy |
1,242,404
+592,125
| +91% | +$10.2M | 0.04% | 389 |
|
|
2025
Q1 | $41.7M | Buy |
650,279
+192,584
| +42% | +$12.3M | 0.08% | 221 |
|
|
2024
Q4 | $55.3M | Buy |
457,695
+26,597
| +6% | +$3.21M | 0.1% | 194 |
|
|
2024
Q3 | $53.9M | Buy |
431,098
+101,253
| +31% | +$12.7M | 0.1% | 207 |
|
|
2024
Q2 | $52.1M | Buy |
329,845
+137,988
| +72% | +$21.8M | 0.1% | 200 |
|
|
2024
Q1 | $24.8M | Buy |
191,857
+45,028
| +31% | +$5.83M | 0.05% | 353 |
|
|
2023
Q4 | $14.2M | Buy |
+146,829
| New | +$14.2M | 0.03% | 477 |
|
|
2021
Q3 | – | Sell |
-5,052
| Closed | -$393K | – | 1067 |
|
|
2021
Q2 | $393K | Sell |
5,052
-2,932
| -37% | -$228K | ﹤0.01% | 956 |
|
|
2021
Q1 | $596K | Buy |
7,984
+238
| +3% | +$17.8K | ﹤0.01% | 899 |
|
|
2020
Q4 | $1.32M | Buy |
7,746
+215
| +3% | +$36.6K | ﹤0.01% | 806 |
|
|
2020
Q3 | $1.06M | Buy |
7,531
+3,228
| +75% | +$453K | ﹤0.01% | 794 |
|
|
2020
Q2 | $690K | Sell |
4,303
-69
| -2% | -$11.1K | ﹤0.01% | 824 |
|
|
2020
Q1 | $428K | Buy |
4,372
+119
| +3% | +$11.7K | ﹤0.01% | 847 |
|
|
2019
Q4 | $549K | Buy |
4,253
+88
| +2% | +$11.4K | ﹤0.01% | 871 |
|
|
2019
Q3 | $314K | Buy |
+4,165
| New | +$314K | ﹤0.01% | 901 |
|